10X Genomics
Karen Bunting is a seasoned professional in R&D operations and scientific research with extensive experience in genomics and molecular biology. Currently serving as Senior Director of R&D Operations at 10x Genomics since March 2022, Karen previously held roles at the New York Genome Center, where the positions included Senior Director of Strategic Initiatives and Chief of Staff to the President and COO. Prior to that, experience includes a research associate position at Weill Cornell Medicine focusing on gene expression in hematology and post-doctoral research on T cell gene transcription at The Australian National University. Karen holds a PhD in Biochemistry and Molecular Biology from The Australian National University and a Bachelor of Science with honors from The University of Adelaide.
10X Genomics
18 followers
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.